Sequent Scientific Limited
NSE:SEQUENT.NS
213.12 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sequent Scientific Limited |
Symbool | SEQUENT.NS |
Munteenheid | INR |
Prijs | 213.12 |
Beurswaarde | 53,190,915,840 |
Dividendpercentage | 0% |
52-weken bereik | 92.05 - 240.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Rajaram Narayanan |
Website | https://www.sequent.in |
An error occurred while fetching data.
Over Sequent Scientific Limited
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)